File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Surveillance findings in high-risk patients after baseline computer-assisted detection colonoscopy: a propensity score matching analysis

TitleSurveillance findings in high-risk patients after baseline computer-assisted detection colonoscopy: a propensity score matching analysis
Authors
Issue Date1-Jan-2025
PublisherElsevier
Citation
Gastrointestinal Endoscopy, 2025, v. 102, n. 3, p. 384-390.e2 How to Cite?
AbstractBackground and Aims: The impact of computer-assisted detection (CADe) on surveillance colonoscopy findings remains unknown. We compare surveillance colonoscopy findings in patients with high-risk lesions detected at baseline, with or without the application of CADe. Methods: We included patients with high-risk baseline lesions who had undergone surveillance colonoscopy. High-risk baseline lesions included advanced adenoma, advanced serrated lesion, or 3 or more adenomas at baseline colonoscopy. Patients were divided into 2 groups according to baseline use of CADe (vs conventional detection), and matched by propensity score matching (PSM) in a 1:2 ratio for surveillance interval, baseline characteristics, and index colonoscopy findings. The primary outcome was metachronous advanced adenoma (AA) rate. Results: Of 403 patients with high-risk baseline lesions and surveillance colonoscopy, 162 were included after PSM. In patients with baseline use of CADe, both the advanced adenoma detection rate (11.1% vs 24.1%; P = .05) and the number of advanced adenomas per colonoscopy (0.1 vs 0.3; P = .01) were significantly lower than in those with conventional colonoscopy. Similar pattern was observed for the adenoma detection rate (44.4% vs 63.0%; P = .02) and the number of adenomas detected per colonoscopy (0.6 vs 1.2; P = .01). The cumulative incidence of patients with any metachronous adenoma or serrated lesion was significantly lower in patients with baseline use of CADe than in those with conventional colonoscopy (log rank P = .05). Conclusions: Patients who had CADe use at baseline colonoscopy had significantly lower rates of metachronous lesions, including advanced adenomas, on surveillance colonoscopy.
Persistent Identifierhttp://hdl.handle.net/10722/362842
ISSN
2023 Impact Factor: 6.7
2023 SCImago Journal Rankings: 1.749

 

DC FieldValueLanguage
dc.contributor.authorLui, Thomas K.L.-
dc.contributor.authorKo, Michael K.L.-
dc.contributor.authorTo, Elvis W.P.-
dc.contributor.authorLeung, Wai K.-
dc.date.accessioned2025-10-03T00:35:30Z-
dc.date.available2025-10-03T00:35:30Z-
dc.date.issued2025-01-01-
dc.identifier.citationGastrointestinal Endoscopy, 2025, v. 102, n. 3, p. 384-390.e2-
dc.identifier.issn0016-5107-
dc.identifier.urihttp://hdl.handle.net/10722/362842-
dc.description.abstractBackground and Aims: The impact of computer-assisted detection (CADe) on surveillance colonoscopy findings remains unknown. We compare surveillance colonoscopy findings in patients with high-risk lesions detected at baseline, with or without the application of CADe. Methods: We included patients with high-risk baseline lesions who had undergone surveillance colonoscopy. High-risk baseline lesions included advanced adenoma, advanced serrated lesion, or 3 or more adenomas at baseline colonoscopy. Patients were divided into 2 groups according to baseline use of CADe (vs conventional detection), and matched by propensity score matching (PSM) in a 1:2 ratio for surveillance interval, baseline characteristics, and index colonoscopy findings. The primary outcome was metachronous advanced adenoma (AA) rate. Results: Of 403 patients with high-risk baseline lesions and surveillance colonoscopy, 162 were included after PSM. In patients with baseline use of CADe, both the advanced adenoma detection rate (11.1% vs 24.1%; P = .05) and the number of advanced adenomas per colonoscopy (0.1 vs 0.3; P = .01) were significantly lower than in those with conventional colonoscopy. Similar pattern was observed for the adenoma detection rate (44.4% vs 63.0%; P = .02) and the number of adenomas detected per colonoscopy (0.6 vs 1.2; P = .01). The cumulative incidence of patients with any metachronous adenoma or serrated lesion was significantly lower in patients with baseline use of CADe than in those with conventional colonoscopy (log rank P = .05). Conclusions: Patients who had CADe use at baseline colonoscopy had significantly lower rates of metachronous lesions, including advanced adenomas, on surveillance colonoscopy.-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofGastrointestinal Endoscopy-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleSurveillance findings in high-risk patients after baseline computer-assisted detection colonoscopy: a propensity score matching analysis -
dc.typeArticle-
dc.identifier.doi10.1016/j.gie.2025.01.036-
dc.identifier.pmid39914631-
dc.identifier.scopuseid_2-s2.0-105000696012-
dc.identifier.volume102-
dc.identifier.issue3-
dc.identifier.spage384-
dc.identifier.epage390.e2-
dc.identifier.issnl0016-5107-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats